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Abstract
HMG20A (also known as iBRAF) is a chromatin factor involved in neuronal differentiation and maturation. Recently
small nucleotide polymorphisms (SNPs) in the HMG20A gene have been linked to type 2 diabetes mellitus (T2DM) yet
neither expression nor function of this T2DM candidate gene in islets is known. Herein we demonstrate that HMG20A
is expressed in both human and mouse islets and that levels are decreased in islets of T2DM donors as compared to
islets from non-diabetic donors. In vitro studies in mouse and human islets demonstrated that glucose transiently
increased HMG20A transcript levels, a result also observed in islets of gestating mice. In contrast, HMG20A expression
was not altered in islets from diet-induced obese and pre-diabetic mice. The T2DM-associated rs7119 SNP, located in
the 3′ UTR of the HMG20A transcript reduced the luciferase activity of a reporter construct in the human beta 1.1E7 cell
line. Depletion of Hmg20a in the rat INS-1E cell line resulted in decreased expression levels of its neuronal target gene
NeuroD whereas Rest and Pax4 were increased. Chromatin immunoprecipitation conﬁrmed the interaction of HMG20A
with the Pax4 gene promoter. Expression levels of Mafa, Glucokinase, and Insulin were also inhibited. Furthermore,
glucose-induced insulin secretion was blunted in HMG20A-depleted islets. In summary, our data demonstrate that
HMG20A expression in islet is essential for metabolism-insulin secretion coupling via the coordinated regulation of key
islet-enriched genes such as NeuroD and Mafa and that depletion induces expression of genes such as Pax4 and Rest
implicated in beta cell de-differentiation. More importantly we assign to the T2DM-linked rs7119 SNP the functional
consequence of reducing HMG20A expression likely translating to impaired beta cell mature function.
Introduction
Type 2 Diabetes Mellitus (T2DM) is a metabolic disease
characterized by impaired insulin secretion and/or action
in target organs that leads to elevations in blood glucose
levels. Environmental factors as well as strong genetic
components contribute to the pathogenesis of T2DM.
Thus far, 100–120 susceptibility loci have been associated
to T2DM by Genome Wide Association Studies
(GWAS)1–3. Although functional defects remain to be
© The Author(s) 2018
OpenAccessThis article is licensedunder aCreativeCommonsAttribution 4.0 International License,whichpermits use, sharing, adaptation, distribution and reproduction
in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if
changesweremade. The images or other third partymaterial in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to thematerial. If
material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Correspondence: Benoit R Gauthier (benoit.gauthier@cabimer.es)
1Department of Cell Regeneration and Advanced Therapies, Andalusian Center
of Molecular Biology and Regenerative Medicine-CABIMER, Junta de
Andalucia-University of Pablo de Olavide-University of Seville-CSIC, Seville,
Spain
2Department of Genome Biology, Andalusian Center of Molecular Biology and
Regenerative Medicine (CABIMER) JA-CSIC-UPO-US, Seville, Spain
Full list of author information is available at the end of the article
These authors contributed equally: Jose M. Mellado-Gil, Esther Fuente-Martín.
Edited by M. Agostini
Ofﬁcial journal of the Cell Death Differentiation Association
12
34
56
78
90
()
:,;
12
34
56
78
90
()
:,;
b
DAPIINSHMG20A
d
c
DAPIGLUCHMG20A DAPISMTHMG20A
DAPIINSHMG20A DAPIGLUCHMG20A DAPISMTHMG20A
a
Fig. 1 (See legend on next page.)
Mellado-Gil et al. Cell Death and Disease  (2018) 9:279 Page 2 of 15
Ofﬁcial journal of the Cell Death Differentiation Association
assigned, many of these loci point to primary defects in
beta cell function rather than to insulin resistance4. In this
context, several SNPs within the HGM20A gene (also
known as iBRAF) have been associated to T2DM5–8. Of
particular interest is the rs7119 SNP located within the 3′
UTR of the HMG20A transcript. In silico analysis revealed
that rs7119 modiﬁes a functional microRNA (miRNA)
cis-regulatory element9. However, the molecular con-
sequences of this SNP on the expression of HMG20A
and/or its regulation and impact on islet physiology are
still unknown.
HMG20A is a member of the high mobility group
(HMG) box-containing genes that binds to chromatin and
exerts global genomic changes through establishing active
or silent chromatin10. HMG20A is highly expressed in
mature neurons and plays a key role in promoting neu-
ronal differentiation during development11. In this con-
text, HMG20A relieves the transcriptional repression
imposed by the complex LSD1–CoREST histone deme-
thylase12, which function is to silence neuronal genes in
non-neuronal tissues through its interaction with the
transcription factor REST. In analogy, epigenetic repres-
sion of the Rest gene in pancreatic precursors was shown
to coincide with the activation of the core beta cell pro-
gram13. Mature pancreatic beta cells do not express REST
while forced expression results in inhibition of neuronal
proteins of the insulin exocytotic machinery such as
SNAP25 and SYNAPTOTAGMIN VII (SYT7) leading to
impaired glucose-induced insulin secretion14. Interest-
ingly, REST was shown to repress expression of key beta
cell development genes, such as NEUROD and PAX415,16.
NEUROD is a bona ﬁde target gene of HMG20A in
neuronal cells11 and mutations in this gene predispose
individuals to maturity onset diabetes of the young 6
(MODY6)17.
HMG20A is also implicated in epithelial-to-
mesenchymal transition (EMT) through interaction with
speciﬁc key regulators of this process such as SNAIL18.
EMT is an example of cell plasticity and a key process
during embryonic development, and together with the
reverse transformation, the mesenchymal-to-epithelial
transition (MET), are required for the formation of
organs in the ﬁnal destinations of embryonic migratory
cells19,20. Both processes occur during pancreatic and islet
development and require extensive reorganization of the
epigenetic information of the cells. Remarkably, not only
in development but also in response to different physio-
logical demands, beta cells may de-differentiate in order
to acquire plasticity capabilities and increase survival21,22,
two processes that may implicate PAX423,24.
Based on these ﬁndings, we hypothesized that HMG20A
may contribute to the regulation of key genes such as
NeuroD and Pax4 which are essential for beta cell func-
tional maturity as well as survival. Towards this goal,
herein we investigate the expression proﬁle and the gene
regulatory function of HMG20A in pancreatic islets, as
well as determine whether the SNP rs7119 associated with
T2DM impacts HMG20A expression. We report that
T2DM-associated SNP rs7119 leads to altered HMG20A
expression, and that HMG20A regulates metabolism-
secretion coupling genes as well as functional maturity of
beta cells.
Results
HMG20A is expressed in pancreatic islets and transcript
levels are decreased in islets from T2DM donors
As a ﬁrst step to assign a potential role of the HMG20A
gene in pancreatic islet physiology, we determined its
transcript levels in islets as compared to other tissues.
Mouse pancreatic islets displayed comparable expression
levels of Hmg20a to other organs such as adipose tissue
(white and brown), brain and muscle whereas the liver
displayed highest levels (Fig. 1a). HMG20A co-stained
with INSULIN (beta cells), GLUCAGON (alpha cells) and
SOMATOSTATIN (delta cells) whereas its expression
was rarely detected in exocrine pancreas (Fig. 1b). A
similar endocrine cell expression pattern was detected in
human islets (Fig. 1c). We next assessed whether
expression levels of HMG20A were altered in islets iso-
lated from T2DM donors. The rational was to establish a
correlation between HMG20A levels and the hypergly-
cemic environment that may be altered by T2DM-linked
SNPs. HMG20A transcript levels were decreased by ~60 %
in islets from T2DM patients as compared to islets pur-
iﬁed from normoglycemic control donors (Fig. 1d).
Metabolic stressors modulate HMG20A expression in islets
As HMG20A transcript levels were decreased in T2DM
islets, we reasoned that lipids and/or glucose might alter
its expression. Towards addressing this premise, we used
(see ﬁgure on previous page)
Fig. 1 HMG20A is expressed in both mouse and human islets and is decreased in islets from T2DM donors. a HMG20A transcript levels were
assessed by qPCR in islets, brain, liver, muscle, white adipose tissue (WAT), and brown adipose tissue (BAT) from mice (n = 6). Representative images
of b mouse and c human islets co-stained for HMG20A (green) along with INSULIN (INS), GLUCAGON (GLUC) or SOMATOSTATIN (SMT) (red). Nuclei
are stained using DAPI (blue). Magniﬁcation 40×. White boxes deﬁne areas enlarged in panels bellow. d HMG20A mRNA levels were measured by
qPCR in human islets isolated from normoglycemic (control) or type 2 diabetic (T2DM) organ donors (n = 7). Data are depicted as dot plots with
means ± S.E.M. p values were determined using unpaired two-tailed Student's t-test. **p < 0.01
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our mouse model of 45% high fat diet (HFD)-induced
obesity and pre-diabetes to assess the contribution of
lipids. These mice exhibit a typical 20% increase in body
weight, develop glucose intolerance with the concomitant
increases in insulin and leptin levels and decreased adi-
ponectin levels25. Although these mice developed insulin
resistance, glycaemia is normal due to increased insulin
levels (Fig. 2a, b). Under these conditions, HMG20A
protein levels were not signiﬁcantly changed in islets as
compared to levels in chow-fed control mice (Fig. 2c). In
contrast, short-term exposure of INS-1E cells to palmitate
resulted in a transient reduction in HMG20A transcript
levels (Fig. 2d).
We next assessed the direct action of high glucose on
HMG20A levels in isolated islets. In human islets,
HMG20A expression levels were transiently increased by
approximately twofold at 72 h returning to basal levels by
96 h (Fig. 3a). A similar transient induction pattern, albeit
attaining maximum levels at 48 h, was also observed in
mouse islets and in INS-1E beta cells (Fig. 3b,c). Inter-
estingly, a signiﬁcant decrease was detected INS-1E cells
at 72 h of high glucose exposure (Fig. 3c). It is noteworthy
that expression levels of NEUROD, a bona ﬁde target of
HMG20A, mirrored those of HMG20A in human islets as
well as in INS-1E (Fig. 3d,f), following the same tendency
in mouse islets (Fig. 3e). In order to satisfy metabolic
demand by fetus and mother, glucose metabolism is
altered during pregnancy inducing metabolic stress that, if
ill adapted, will lead to gestational diabetes. We therefore
pondered whether Hmg20a expression levels were
modulated during pregnancy. Consistent with this pre-
mise, transcript and protein levels of the Hmg20a gene
were increased reaching a peak of maximum signal at 12.5
and 14.5 days post coitum, respectively, and thereafter
declining (Fig. 4a–c). Pregnant females displayed mild
glucose intolerance at 14.5 correlating with the peak in
HMG20A protein levels (Fig. 4d). Taken together, these
data suggest that increased glucose levels both in vitro and
in vivo stimulate HMG20A expression.
The rs7119 SNP variant within the 3′ untranslated region
(UTR) of human HMG20A reduces activity of a luciferase
reporter gene
Although GWAS have highlighted a panoply of SNPs
correlating with T2DM, few have been assigned a func-
tional consequence to the associated gene. Towards
addressing this question, we assessed whether the human
HMG20A SNPs associated to T2DM may impact
HMG20A levels. Of particular interest is the SNP rs7119
located in the 3′ UTR of the HMG20A transcript that is
encoded in part by exon 10 and the entirety of exon 11
(Fig. 5c). The SNP rs7119 causes a “C” (reference allele
“wt”) to “T” (“mut” allele) substitution. In silico analysis of
Fig. 2 HMG20A protein expression is not altered in islets of high
fat diet (HFD)-induced obesity and pre-diabetic mice. a Insulin
tolerance test (ITT) and area under the curve (AUC) analysis in both
control (CT) and HFD mice (CT, n = 10; HFD, n = 15). b Fasting blood
glucose levels in both control and HFD mice (CT, n = 10; HFD, n = 15).
c Representative images of pancreatic sections from HFD and CT mice
stained and quantiﬁed for HMG20A (n = 4). d Hmg20a mRNA levels
were assessed by qPCR in INS-1E cells cultured with 0.05 mM
palmitate for 24, 48, 72 or 96 h (n = 3 independent experiments
performed in triplicates). Data are represented as means + S.E.M. p
values were determined by ordinary one-way ANOVA. *p < 0.05, **p <
0.01, ***p < 0.0001
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the HMG20A 3′UTR revealed the binding site of a single
miRNA (miR-571) to the wt allele whereas the “mut” allele
results in the ablation of this miRNA binding site
(Table 1). Interestingly expression of miR-571 was not
detected in mouse islets as compared to the highly
expressed miR375 (data not shown). Notwithstanding, the
Fig. 3 HMG20A is regulated by glucose. a–c HMG20A and d–f NEUROD mRNA levels were assessed by qPCR in human (n = 3 donors performed in
triplicates) and mouse islets (three independent preparations of pooled islets from three different isolation) as well as INS-1E cells cultured in 24 mM
glucose for 24, 48, 72, or 96 h (n = 3 independent experiments of all time points executed in triplicates). Data are represented as means + S.E.M. p
values were determined by ordinary one-way ANOVA. *p < 0.05, compared to the control 0 time point
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Fig. 4 HMG20A is transiently increased in mouse islets during pregnancy. a Representative images of pancreatic sections from pregnant mice
co-stained for HMG20A (green) and INSULIN (INS) (red). Nuclei were stained using DAPI (blue). Magniﬁcation 40×. White boxes deﬁne areas enlarged
in panels below. p.c. post coitum. b Quantiﬁcation of integrated ﬂuorescence intensity for HMG20A in beta cells of islets from pregnant mice (n = 3
mice per time point with 35-71 islets counted per time point). Data are depicted as dot plots with means ± S.E.M. c HMG20A mRNA levels in islets
from pregnant mice (n = 5 mice) at 12.5 and 14.5 days of pregnancy. d Oral glucose tolerance test (OGTT) and area under the curve (AUC) analysis of
non-pregnant (NP) and pregnant (day 14.5 of pregnancy; D14.5) mice (NP, n = 8; D14.5, n = 6). Data are represented as means ± S.E.M. p values were
determined by the unpaired two-tailed Student´s t-test (d for AUC and c) or ordinary one-way ANOVA with Dunnet’s multiple comparison test (b). *p
< 0.05, **p < 0.01, ****p < 0.0001, compared to the control 0 time point
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Fig. 5 The rs7119 SNP within the HMG20A 3′ UTR decreases protein levels. Expression proﬁle of putative miRNAs binding to the “mut” allele of
the HMG20A transcript in a human 1.1E7 cells and b mouse islets. Data are presented respect to miR375 expression levels. c Schematic
representation of the HMG20A gene depicting the promoter region (HMG20A promoter), transcription starting site (tss) and 11 exons. Gaussia
luciferase (GLuc) reporter constructs harboring the 3′ UTR corresponding to either wild type (wt) or rs7119 mutant (mut) allele under pSV40 promoter
are shown below. d HMG20A mRNA levels assessed by qPCR in the human pancreatic beta cell line 1.1E7 cultured in 24 mM glucose for 24, 48, 72, or
96 h (n = 5 independent experiments performed in triplicates). e Human pancreatic beta 1.1E7 and f RPE1 cell lines were transfected with the reporter
construct bearing either wt or rs7119 mut variant of the HMG20A 3′ UTR. Both the Gaussia Luciferase activity and SEAP activity were determined 24 h
post transfection (n = 3 independent experiments). Data are represented as means + S.E.M. p values were determined by ordinary one-way ANOVA
(d) or unpaired Student's t-test (e, f). *p < 0.05
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“mut” allele generates binding sites for six alternative
miRNAs (Table 1) of which four, miR-143 (3p and 5p),
miR-490-3p, miR-1246, and miR-1261, were expressed in
the human 1.1E7 pancreatic cell line (Fig. 5a). In contrast
mouse islets only expressed miR-143 and very low levels
of miR-1246 (Fig. 5b). The latter ﬁndings suggest that the
“mut” variant may alter expression of the HMG20A
transcript due to the action of those miRNAs. To assess
this premise, we generated two Gaussia luciferase (Gluc)
reporter constructs harboring either the “wt” or “mut” 3′
UTR of the human HMG20A transcript. Expression of
these constructs was under the transcriptional regulation
of the SV40 basal promoter (Fig. 5c). Transient transfec-
tions were then performed in the human pancreatic beta
1.1E7 and retinal pigmented epithelial RPE1 cell lines.
The rational of using human cell lines was to maintain
species-speciﬁc effects targeting the human 3′ UTR of the
HMG20A transcript, which is distinct than that of the
mouse Hmg20a transcript. We initially conﬁrmed that
glucose also stimulated HMG20A expression in 1.1E7 beta
cells (Fig. 5d). The “mut” variant displayed signiﬁcantly
less Gluc activity as compared to the construct bearing
the “wt” variant 48 h post transfection in either cell lines
(Fig. 5e, f). These results suggest that the diabetes-linked
SNP rs7119 alters expression of the human HMG20A.
HMG20A regulates the expression of beta cell genes
involved in metabolism-secretion coupling and beta cell
maturity
To determine the speciﬁc contribution of HMG20A to
islet beta cell function and the impact of its reduced levels
in T2DM islets, we silenced HMG20A expression by RNA
interference and then assessed transcript levels of key
factors involved in beta cell identity and function. A 60%
depletion of Hmg20a in INS-1E cells (Fig. 6a, b) resulted
in a concomitant 60% inhibition of NeuroD transcript
levels (Fig. 6c). Mafa, which is essential to maintain the
beta cell phenotype, was decreased by 50% whereas Pdx1
was unaltered. Interestingly, Pax4 as well as Rest were
increased by 1.8- and 1.5-fold, respectively, subsequent to
Hmg20a silencing (Fig. 6c). We previously demonstrated
that chronic overexpression of Pax4 leads to loss of beta
cell identity characterized by decreased Mafa and Insulin
expression23. We thus, pondered whether HMG20A
could directly regulate Pax4 thereby maintaining its
expression within a range that would not interfere with
beta cell function. To validate this premise, chromatin
immunoprecipitation (ChIP) experiments were performed
using the islet speciﬁc Pax4 gene promoter24. As expected
H3K4me2, a marker for active promoters and enhancers
speciﬁcally occupied this region (Fig. 6d)26. More
importantly, HMG20A also occupied the Pax4 gene
promoter region as well as exon 1 while control anti-IgG
exhibited no binding (Fig. 6e). Since NEUROD and
MAFA are involved in metabolism-secretion coupling in
beta cell, genes implicated in this process were assessed
after Hmg20a silencing. Glucokinase (Gck) and Insulin
transcript levels were signiﬁcantly repressed by 30%
(Fig. 6f). In contrast, Pi3k and Glut2 levels were increased
1.8 and 2.6-fold, respectively (Fig. 6f). Transcript levels of
Syt7 and Snap25, two factors involved in insulin granule
membrane docking and fusion were not altered in
Hmg20a-repressed INS-1E cells (Fig. 6f). The modulation
of key HMG20A target genes was validated using a second
independent siHMG20A (Fig. 6g). Taken together our
results indicate that HMG20A coordinates expression of
genes that will establish the mature beta cell phenotype.
Glucose-stimulated insulin secretion is impaired by
Hmg20a depletion
We next assess the cellular and functional consequences
of Hmg20a depletion in beta cells. Neither cell death nor
proliferation was altered by HMG20A depletion in INS-
1E cells (Fig. 7a, b). In contrast, glucose-stimulated insulin
secretion (GSIS) was blunted in these cells (Fig. 7c).
Similarly, subsequent to a 40% depletion of Hmg20a in
mouse islets (Fig. 7d), cell proliferation was unaltered
while GSIS was drastically decreased as compared to
control islets (Fig. 7e, f). Taken together, Hmg20a
expression is essential for insulin secretion.
Discussion
The overall aim of the current study was to assign a
functional role of the putative diabetes-linked HMG20A
gene to islet physiology, and determine the pathophysio-
logical consequence of the rs7119 SNP associated with
this disease. We ﬁnd that: (1) HMG20A is expressed in
pancreatic islet beta cells, (2) HMG20A levels are
decreased in T2DM islets, (3) high glucose stimulates
HMG20A expression, (4) the T2DM-associated SNP
within the 3′ UTR of the HMG20A transcript decreases
luciferase activity, (5) HMG20A regulates key genes in
beta cell function and maturity, and (6) HMG20A
TABLE 1 In silico identiﬁcation of miRNAs binding sites
within the rs7119 SNP located in the 3′UTR of HMG20A
“C” reference alelle “T” risk allele
(wt) (mut)
hsa-miR-571 hsa-miR-1261
hsa-miR-1257
hsa-miR-1246
hsa-miR-586
hsa-miR-490 (5p, 3p)
hsa-miR-143 (5p, 3p)
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Fig. 6 HMG20A regulates metabolism-secretion coupling genes in INS-1E cells. a Hmg20a was silenced by speciﬁc siRNA in INS-1E cells (n = 6
independent experiments, each performed in triplicates). b Representative images of INS-1E cells immuno-stained for HMG20A (green) and DAPI
(blue) conﬁrming decreased protein level after treatment with siHMG20A. Magniﬁcation 40×. c Beta cell development and maturity genes, as Neurod,
Pax4, Mafa, Pdx1, and Rest transcripts levels after silencing of Hmg20a in INS-1E cells (n = 4 independent experiments performed in triplicates). d
H3K4m2 and e HMG20A occupancy of promoter, exon 1 and ATG regions of the Pax4 gene after chromatin immunoprecipitation using anti-H3K4m2
or anti-HMG20A antibodies, with IgG as a control for non-speciﬁc interactions (n = 4 independent experiments performed in triplicates). f Beta cell
metabolism-secretion coupling genes transcripts levels after silencing of Hmg20a in INS-1E cells (n = 4 independent experiments, performed in
triplicates). g Alteration in the expression of key genes was conﬁrmed in INS-1E cells using a second siHMG20A (n = 4 independent experiments
performed in triplicates). Data are represented as means + S.E.M. p values were determined by one-way ANOVA with Tukey’s multiple comparisons
test (a, c, f, g). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001
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depletion impairs GSIS. Therefore, we provide ﬁrst evi-
dence that HMG20A is a key regulator of mature beta cell
function.
Our results indicate that variations in glucose levels are
a main rheostat of islet HMG20A expression, which in
turn appears to modulate islet adaptive measures by
increasing insulin biosynthesis. The latter premise is
supported by our ﬁndings that NEUROD expression levels
mirrored those of HMG20A, being stimulated by high
glucose and inhibited under siRNA-mediated Hmg20a
downregulation. Mutations in the NEUROD gene
predispose individuals to develop maturity onset diabetes
of the young (MODY6)17 while adult mouse islets lacking
Neurod respond poorly to glucose27. We also found
reduced expression levels of Mafa as a consequence of
Hmg20a depletion. This transcription factor along with
NEUROD activates expression of the Gck and Insulin
gene27–29, consistent with reduced levels of both tran-
scripts in Hmg20A-silenced cells. Intriguingly, Glut2 was
increased following Hmg20a repression perhaps as a
compensatory mechanism to increase cellular glucose
inﬂux due to decreased GCK-mediated phosphorylation
Fig. 7 Hmg20a silencing impairs insulin secretion in INS-E1 cells as well as in mouse islets without affecting cell death or proliferation. a
Cell death (n = 3), b proliferation (n = 3), and c glucose-induced insulin secretion (GSIS, n = 4) were assessed subsequent to siRNA-mediated HMG20A
depletion in INS-1E cells. d Effect of siRNA-mediated HMG20A depletion on e cell proliferation (n = 6 islet preparations) and f GSIS in mouse islets (n
= 6 islet preparations). Data are represented as mean + S.E.M. p values were determined by unpaired two-tailed Student's t-test. *p < 0.05, **p < 0.01
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and glycolysis30. Thus, the coordinated regulation of
NeuroD and Mafa by HMG20A may be a key molecular
hub essential for beta cell function and adaptation to
physiological stress such as during pregnancy in which
glucose metabolism is altered. Interestingly, although
HMG20A was repressed by palmitate in vitro, expression
levels were not signiﬁcantly altered in islets of a mouse
model of high fat diet-induced obesity and pre-diabetes.
Thus, it is tempting to speculate that in vivo, glucose and
lipids may have opposite effect on HMG20A expression
nullifying any signiﬁcant increased in expression, which
may in long-term hinder islet adaptation, precipitating
beta cell dysfunction and T2DM. The latter hypothesis
may rationalize the observed association of HMG20A risk
variants with T2DM in obese cases8.
Our study also identiﬁes the Pax4 gene as a direct target
repressed by HMG20A. Although the Pax4 gene pro-
moter was shown to interact with REST15, the absence of
this “disallowed” gene in beta cells suggest that HMG20A
acts independent of the LSD1–coREST complex that
requires REST to be recruited onto DNA14. Rather, our
results are in agreement with recent ﬁndings that
HMG20A in cohort with LSD1 is sufﬁcient to repress
Snail1 and induce TGF beta-triggered EMT, demon-
strating a mechanism independent of REST as well as the
capacity of HMG20A for binding directly to DNA18.
Notwithstanding, Hmg20a silencing also evoked REST re-
expression indicating that in cohort with PAX4, these two
factors may promote de-differentiation of beta cells con-
veying increased survival under unfavorable physiological
conditions such as chronic hyperglycemia.
To date, regulation of the endogenous Pax4 gene in
mature islets conveying protection and adaptation in
response to physiological or pathophysiological condi-
tions has remained obscure. Our data suggest that
HMG20A may be an important epigenetic regulator of
Pax4 gene expression that will dictate the faith of beta
cells under stress conditions such as in T2DM. In accord
with this premise, we previously demonstrated that PAX4
expression was increased in islets derived from T2DM
patients31. We now demonstrate that HMG20A levels are
repressed in T2DM islets. These combined human data
are in line with increased expression of Pax4 subsequent
to Hmg20a silencing in either islets or INS-1E cells
without altering apoptosis and proliferation. Accumulat-
ing evidence suggest that the main characteristic event in
T2DM is not massive beta cell death but rather beta cell
de-differentiation32. We previously demonstrated that
chronic expression of Pax4 is implicated in this process
through downregulation of Mafa and Insulin expres-
sion33. Our current data substantiate these ﬁndings as we
detected a decrease in Mafa expression after Hmg20a
silencing. Thus, the role of HMG20A may be to supress
Pax4 transcription thereby permitting expression of Mafa
as well as Insulin. Such cross talk between the two factors
is highlighted also during pregnancy. Indeed, we pre-
viously found a peak of Pax4 expression and beta-cell
proliferation at 10.5 days and 12.5 days of pregnancy
respectively24. Herein, we now ﬁnd that HMG20A
expression in islets is increased at 14.5 days of pregnancy,
just after the peak of proliferation and correlating with
decreased Pax4 and increased Mafa expression levels.
These ﬁndings are consistent with the premise that beta
cells after proliferation have to re-differentiate to reach
their metabolic mature phenotype and adequately secrete
insulin, a process requiring MAFA34. A similar regulatory
cross talk between HMG20A and PAX4 may also be
operative in early stages of hyperglycemia, which is
characterized by active beta cell adaptation. Nonetheless,
long-term exposure may favor de-differentiation and
survival (without altering proliferation) to the detriment
of function, as we observed in vitro in which HMG20A
expression was transiently increased but then inhibited by
glucose. Although further studies will be needed to specify
the mechanism by which HMG20A regulates those islet-
enriched genes, our work provides the basis for the
involvement of a non-mutually exclusive cross regulation
of HGM20A and PAX4 in islet/beta cell physiology.
A signiﬁcant ﬁnding of our study is the potential
decreased in HMG20A levels associated with the
diabetes-linked rs7119 SNP within the 3′ UTR of the
transcript. This SNP opens the putative binding site of
several new miRNAs as compared to the normal wild type
allele. Although a previous study has linked T2DM-
associated genes to islet-expressed miRNA35, our study, to
the best of our knowledge, provides ﬁrst evidence that a
diabetes-linked SNP alters the putative binding site for
miRNAs resulting in the deregulate repression of the
target transcript. Further indication for a dysfunctional
role of the rs7119 variant in aberrant HMG20A repression
was highlighted by the expression of SNP-associated
miRNAs, the most abundant being miR-143 and 1246, in
human 1.1E7 cells and mouse islets. In contrast, miR-571
associated with the wild type allele miRNA binding site
was not express suggesting the potential absence of post-
transcriptional regulation conveyed by the normal allele.
Although scarce details are available on the role of miR-
143 and 1246 in islet function, miR-143 was shown to be
among the ten most abundant miRNAs expressed in
human islets beta cells whereas miR-1246 was pre-
dominantly expressed in other islet cell types35. Else-
where, miR-143 expression was found to be essential for
human pre-adipocyte differentiation partly through
repression of its target gene ERK5 involved in cell growth
and proliferation36. Although it remains to be validated,
the potential serendipitous binding of miR-143 to the
HMG20A rs7119 gene variant may induce aversely de-
differentiation through activation of Pax4 and Rest.
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The overall data presented in this work clearly describes
a functional link between HMG20A and islet physiology.
HMG20A regulates metabolism-secretion coupling genes
in beta cells and could be also involved in beta cell plas-
ticity through PAX4 and REST, regulating phenotypic
changes needed for beta cells in order to respond to dif-
ferent physiological situations as pregnancy and obesity.
Failure on those HMG20A-mediated processes could lead
to the development and establishment of T2DM. As
consequence, our study opens a venue to consider tar-
geting of HMG20A expression and/or regulation as
potential therapies for T2DM.
Materials and methods
Animals
The experimental mouse procedures were approved by
the Institutional Animal Care Committee of the Andalu-
sian Center of Molecular Biology and Regenerative Medi-
cine (CABIMER) and by the ethic committee of the
University of Malaga, Biomedical Research Institute of
Málaga (IBIMA) and performed according to the Spanish
law on animal use RD 53/2013. Animal studies were per-
formed in compliance with the ARRIVE guidelines37. Mice
were housed in ventilated plastic cages and maintained on
a 12-h light–dark cycle with ad libitum access to pelleted
chow and water. C57BL/6J of both genders were used to
obtain pancreatic islets and other tissues (liver, adipose
tissue, skeletal muscle, and brain) and females for preg-
nancy studies. For diet-induced obesity studies, 8-weeks-
old male C57BL/6J mice (Janvier Labs, Saint-Berthevin
Cedex, France) were housed in individual cages under a 12
h light/dark cycle (8:00 pm light off) in a room with con-
trolled temperature (21± 2 °C) and humidity (50± 10%).
For induction of obesity, groups of ten mice were fed a high
fat diet (D12451 Research Diets Inc., New Brunswick, NJ,
USA), containing 45% of Kcal from saturated fat, for
15 weeks. In parallel, groups of ten age-matched mice were
fed a control diet containing 10% of Kcal from fat (D12450
Research Diets Inc.). Circulating glucose levels were mea-
sured from tail vein blood samples using an Optium Xceed
glucometer (Abbott Scientiﬁca SA, Barcelona, Spain).
Insulin tolerance tests (ITT) and glucose tolerance test
(OGTT) were performed as previously described38. At
15 weeks, mice were sacriﬁced by cervical dislocation and
pancreas extracted for histological processing.
Pancreatic islet and cell line cultures
Mouse pancreatic islets were isolated from 2 to 4-
months-old C57BL/6J mice by intraductal collagenase as
previously described24,39 . After isolation, mouse islets
were cultured in 5.5 mM glucose/RPMI 1640 medium
(Life Technologies, Madrid, Spain) supplemented with 10
% Fetal bovine serum (FBS, Sigma-Aldrich, Madrid,
Spain), 100 U/ml penicillin, 100 μg/ml streptomycin
(Sigma-Aldrich), 2 mM L-glutamine (Life Technologies),
1 mM sodium pyruvate (Sigma-Aldrich), 50 μM β-
mercaptoethanol (Life Technologies), and 10mM
HEPES (Life Technologies) prior to different experimental
treatments. Islets from non-diabetic or T2DM organ
donors were obtained in Pisa or purchased from Tebu-Bio
(Barcelona, Spain). After reception, human islets were
cultured in CMRL-1066 (Gibco) medium containing 5.5
mM glucose and supplemented with 10% FBS, 100 U/ml
penicillin, 100 μg/ml streptomycin, 2 mM L-glutamine,
and 100 μg/ml gentamycin. To assess glucose inﬂuence in
HMG20A expression, both human and mice islets were
cultured in normal (5.5 mM) or high (24.4 mM) glucose
concentrations for 24, 48, 72, and 96 h, and lately har-
vested for RNA extraction.
The rat insulinoma INS-1E beta cell line (kindly pro-
vided by Dr. P Maechler, Geneva, CH) was cultured
between passages 50–90 and maintained in 11.1 mM
glucose/RPMI 1640 medium (Life Technologies) supple-
mented with 10% FBS, 100 U/ml penicillin, 100 μg/ml
streptomycin, 2 mM L-glutamine, 1 mM sodium pyruvate,
50 μM β-mercaptoethanol, and 10mM HEPES. Following
overnight glucose deprivation (3 mM), cells were cultured
in 11.1 mM or 24.4 mM glucose RPMI 1640 medium for
24, 48, 72, and 96 h. Alternatively INS-1E cells were also
exposed to 0.5 mM palmitate for up to 96 h. Cells were
harvested at each time point for RNA extraction.
The human retinal pigmented epithelial RPE1 (ATCC,
CRL-4000) and the islet beta 1.1E7 cell lines (The Eur-
opean Collection of Authenticated Cell Cultures) were
cultured in F-12 Ham and RPMI media, respectively, prior
to luciferase reporter assays. The 1.1E7 cell line was also
cultured in the presence of either 11.1 or 24.4 mM glucose
for up to 96 h. RNA was extracted at 24, 48, 72, and 96 h
post treatment.
RNA interference
Mouse pancreatic islets and INS-1E cells were cultured
as previously described40 and transfected with either 50
μmol of two independent HMG20A small interfering (si)
RNAs (5′-AGGCAAAUCUCAUAGGCAA-3′ and 5′-
UCACAAGGAUGUUGGGCAA-3′) or scramble siRNA
(Sigma-Aldrich) using Oligofectamine (Life Technolo-
gies). Samples were processed for RNA, immuno-
ﬂuorescence, GSIS, cell proliferation and death
assessment 72 h after transfection.
RNA extraction and quantitative-PCR expression analysis
Qiagen RNeasy Micro and Mini kits (Qiagen, Madrid,
Spain) were used for the extraction of total RNA from the
different tissues, islets and cell line samples. After quan-
tiﬁcation of the RNA concentration using a NanoDrop
1000 Spectrophotometer (Wilmington, DE, USA), single-
stranded cDNA was synthesized with the Superscript II
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First-Strand cDNA synthesis kit (Invitrogen, Carlsbad,
CA, USA) and Anchored OligodT as primers (Sigma-
Aldrich). Quantitative PCR was performed on a 7500
Real-Time PCR System (Applied Biosystems). Gene-
speciﬁc primers (HMG20A, NEUROD1, PDX1, PAX4,
REST, GLUKOKINASE, INSULIN, PI3K, MAFA, GLUT1,
GLUT2, SNAP25, and SYT7) were designed using Power
Primer3 (Supplementary Table 1, 2 and 3). Expression
levels of the housekeeping genes β-ACTIN or CYCLO-
PHILIN were used for normalization. The relative gene
expression was calculated using the 2−ΔΔCt method24. For
miRNA expression proﬁling, microRNAs were extracted
from the 1.1E7 beta cell line and mouse pancreatic islets
using the miRNAeasy kit (Qiagen) and cDNA synthesis
was conducted using the Universal cDNA Synthesis Kit
(Exiqon) as previously described41. ExiLENT SYBR Green
Master Mix Kit and primers for each assay to perform
quantitative-PCR (qPCR) were obtained from Exiqon.
Immunoﬂuorescence and immunohistochemistry studies
Dissected pancreases were ﬁxed overnight in 4% par-
aformaldehyde at 4 °C and processed for embedding in
parafﬁn at the Histology Core Facility, CABIMER. Pan-
creatic sections from non-pregnant/pregnant mice sacri-
ﬁced at 10.5, 12.5, 14.5, and 17.5 days post coitum were
analyzed by immunohistochemistry using speciﬁc anti-
bodies against HMG20A, insulin, glucagon, and soma-
tostatin (Supplemental Table 4). Counterstaining was
performed with 5 μg/ml DAPI (Life Technologies) to stain
the nuclei and slides were mounted using ﬂuorescent
mounting medium (DAKO). Images were acquired using
either the epiﬂuorescence (Leica AF6000, Leica, England)
or confocal (Leica TCS SP5) microscopes. Expression of
HMG20A in beta cells was quantiﬁed using Metamorph
Analysis Software (Molecular Devices). Single frames
were acquired using a confocal TCS SP5 microscope
(Leica). Same illumination settings were applied for all the
samples (image parameters including pinhole size, pho-
tomultiplier offset and gain, and laser intensity were ﬁrst
set for non-pregnant control samples, and then, the same
settings were used for all conditions). For Image analysis/
quantiﬁcation, the integrated intensity values (∑ pixel
intensity at region of interest) were measured as pre-
viously described42–44. Integrated intensity of nuclear
HMG20A in islet cells co-expressing insulin were mea-
sured, and the average of intensity per islet was calculated.
Three independent animals and an average of 50 islets
were used for each time point. Pancreatic sections from
control and HFD mice were performed and analyzed as
previously described25.
Luciferase 3′ UTR reporter assays
The effect of the 3′ UTR SNP rs7119, previously linked
to T2DM was evaluated by luciferase reporter assays. 3′
UTR constructs containing the wt allele (reference allele)
“C” or the DMT2-linked allele (“mut” allele) “T” cloned
downstream of the luciferase gene were obtained from
GeneCopoeia. Luciferase contained in these constructs is
a secreted one; therefore luciferase activity can be mea-
sured in the medium. These constructs also have a
secreted embryonic alkaline phosphatase (SEAP) gene
driven by a constitutive promoter, used as internal con-
trol. The Secrete-Pair TM Dual Luminescence Assay Kit
(GeneCopoeia) was used as luciferase reporter system
according to manufacturer’s instructions. RPE1 and 1.1E7
cell lines were chosen for transfection studies using those
constructs. Both are cell lines of human origin and from
different tissues. RPE1 are cells from retina pigmentosum
ephitelia45 meanwhile 1.1E746 is a human beta cell line.
The RPE1 and 1.1E7 cell lines were transfected and
luciferase activity was measured 48 h after in the collected
culture media.
Glucose-stimulated insulin secretion assays
Insulin secretion in response to 2.8 mM or 22mM
glucose was measured in static incubations as previously
described47,48 in both mouse pancreatic islets and INS-1E
cells. Following the incubations, supernatants were col-
lected and islets and cells were lysated with HCl-ethanol
to obtain the insulin content. Insulin from supernatants
and cell contents was measured by ELISA (Mercodia,
Uppsala, Sweden). All experiments were run in triplicate.
Cell death and proliferation
Cell death (apoptosis) and proliferation was measured
using either the Cell Death Detection ELISA kit or the 5-
Bromo-2′-deoxy-uridine labeling and detection kit (Roche
Diagnostics, Madrid, Spain) as described by the
manufacturer.
ChIP assays
ChIP assays were performed as previously descri-
bed12,18. INS-1E cells were treated with 1% formaldehyde
for 15 min at 37 °C for crosslinking. Chromatin was
sonicated to an average fragment size of 400 to 500 bp
using the Diagenode Bioruptor. Immunoprecipitations
were performed using the following reagents: Dynabeads
Protein A (Invitrogen), rabbit polyclonal anti-HMG20A
(Sigma-Aldrich) and rabbit monoclonal to Histone H3 (di
methyl K4) (Abcam). Rabbit IgG (Sigma) was used as a
control for non-speciﬁc interactions. Input was prepared
with 10% of the chromatin used for immunoprecipitation.
Quantiﬁcation of immunoprecipitated DNA was per-
formed by real-time PCR with the Applied Biosystems
7500 FAST real-time PCR system, using Applied Biosys-
tems Power SYBR green master mix. Each sample was
quantiﬁed in triplicate. Provided data are the average of at
least three independent experiments.
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Statistical analysis
The Ruth Lenth's power of analysis was applied to the
different animal models to ensure that adequate numbers
of animals had been studied to detect signiﬁcant changes.
Results are expressed as mean± SEM (line plots as a
function of time) or as mean+ SEM (bar graphs). Statis-
tical analyses were performed using the GraphPad Prism
software version 7 (GraphPad Software, La Jolla, USA).
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